{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:04:28Z","timestamp":1789913068873,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:00:00Z","timestamp":1516320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Smith-Lemli-Opitz Syndrome (SLOS) is a recessive human disease caused by defective cholesterol (CHOL) synthesis at the level of DHCR7 (7-dehydrocholesterol reductase), which normally catalyzes the conversion of 7-dehydrocholesterol (7DHC) to CHOL. Formation and abnormal accumulation of 7DHC and 7DHC-derived oxysterols occur in SLOS patients and in rats treated with the DHCR7 inhibitor AY9944. The rat SLOS model exhibits progressive and irreversible retinal dysfunction and degeneration, which is only partially ameliorated by dietary CHOL supplementation. We hypothesized that 7DHC-derived oxysterols are causally involved in this retinal degeneration, and that blocking or reducing their formation should minimize the phenotype. Here, using the SLOS rat model, we demonstrate that combined dietary supplementation with CHOL plus antioxidants (vitamins E and C, plus sodium selenite) provides better outcomes than dietary CHOL supplementation alone with regard to preservation of retinal structure and function and lowering 7DHC-derived oxysterol formation. These proof-of-principle findings provide a translational, pre-clinical framework for designing clinical trials using CHOL-antioxidant combination therapy as an improved therapeutic intervention over the current standard of care for the treatment of SLOS.<\/jats:p>","DOI":"10.1038\/s41598-018-19592-8","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T17:05:19Z","timestamp":1516035919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Prevention of Retinal Degeneration in a Rat Model of Smith-Lemli-Opitz Syndrome"],"prefix":"10.1038","volume":"8","author":[{"given":"Steven J.","family":"Fliesler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Peachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josi","family":"Herron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav I.","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriganesh","family":"Ramachandra Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,19]]},"reference":[{"key":"19592_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/jmg.37.5.321","volume":"37","author":"RI Kelley","year":"2000","unstructured":"Kelley, R. I. & Hennekam, R. C. The Smith-Lemli-Opitz syndrome. J Med Genet 37, 321\u2013335 (2000).","journal-title":"J Med Genet"},{"key":"19592_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ajmg.c.31343","volume":"160C","author":"MJ Nowaczyk","year":"2012","unstructured":"Nowaczyk, M. J. & Irons, M. B. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. Am J Med Genet C Semin Med Genet 160C, 250\u2013262 (2012).","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"19592_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ymgme.2004.09.017","volume":"84","author":"LS Correa-Cerro","year":"2005","unstructured":"Correa-Cerro, L. S. & Porter, F. D. 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome. Mol Genet Metab 84, 112\u2013126 (2005).","journal-title":"Mol Genet Metab"},{"key":"19592_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ajmg.c.31346","volume":"160C","author":"HR Waterham","year":"2012","unstructured":"Waterham, H. R. & Hennekam, R. C. Mutational spectrum of Smith-Lemli-Opitz syndrome. Am J Med Genet C Semin Med Genet 160C, 263\u2013284 (2012).","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"19592_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJM199401133300205","volume":"330","author":"GS Tint","year":"1994","unstructured":"Tint, G. S. et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330, 107\u2013113 (1994).","journal-title":"N Engl J Med"},{"key":"19592_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/ng1134","volume":"33","author":"MK Cooper","year":"2003","unstructured":"Cooper, M. K. et al. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 33, 508\u2013513 (2003).","journal-title":"Nat Genet"},{"key":"19592_CR7","doi-asserted-by":"publisher","first-page":"13037","DOI":"10.1021\/ja9029076","volume":"131","author":"L Xu","year":"2009","unstructured":"Xu, L., Davis, T. A. & Porter, N. A. Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes. J Am Chem Soc 131, 13037\u201313044 (2009).","journal-title":"J Am Chem Soc"},{"key":"19592_CR8","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1021\/ja9080265","volume":"132","author":"L Xu","year":"2010","unstructured":"Xu, L., Korade, Z. & Porter, N. A. Oxysterols from free radical chain oxidation of 7-dehydrocholesterol: product and mechanistic studies. J Am Chem Soc 132, 2222\u20132232 (2010).","journal-title":"J Am Chem Soc"},{"key":"19592_CR9","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1194\/jlr.M018366","volume":"52","author":"L Xu","year":"2011","unstructured":"Xu, L., Liu, W., Sheflin, L. G., Fliesler, S. J. & Porter, N. A. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome. J Lipid Res 52, 1810\u20131820 (2011).","journal-title":"J Lipid Res"},{"key":"19592_CR10","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1194\/jlr.M009365","volume":"51","author":"Z Korade","year":"2010","unstructured":"Korade, Z., Xu, L., Shelton, R. & Porter, N. A. Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome. J Lipid Res 51, 3259\u20133269 (2010).","journal-title":"J Lipid Res"},{"key":"19592_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.exer.2016.01.016","volume":"145","author":"BA Pfeffer","year":"2016","unstructured":"Pfeffer, B. A., Xu, L., Porter, N. A., Rao, S. R. & Fliesler, S. J. Differential cytotoxic effects of 7-dehydrocholesterol-derived oxysterols on cultured retina-derived cells: Dependence on sterol structure, cell type, and density. Exp Eye Res 145, 297\u2013316 (2016).","journal-title":"Exp Eye Res"},{"key":"19592_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.chemphyslip.2005.03.004","volume":"136","author":"EE Berring","year":"2005","unstructured":"Berring, E. E., Borrenpohl, K., Fliesler, S. J. & Serfis, A. B. A comparison of the behavior of cholesterol and selected derivatives in mixed sterol-phospholipid Langmuir monolayers: a fluorescence microscopy study. Chem Phys Lipids 136, 1\u201312 (2005).","journal-title":"Chem Phys Lipids"},{"key":"19592_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.chemphyslip.2009.06.139","volume":"161","author":"KB Lintker","year":"2009","unstructured":"Lintker, K. B., Kpere-Daibo, P., Fliesler, S. J. & Serfis, A. B. A comparison of the packing behavior of egg phosphatidylcholine with cholesterol and biogenically related sterols in Langmuir monolayer films. Chem Phys Lipids 161, 22\u201331 (2009).","journal-title":"Chem Phys Lipids"},{"key":"19592_CR14","first-page":"e119","volume":"3","author":"SJ Fliesler","year":"2013","unstructured":"Fliesler, S. J. On the role of membrane structural defects in Smith-Lemli-Opitz syndrome. J Membra Sci Technol 3, e119 (2013).","journal-title":"J Membra Sci Technol"},{"key":"19592_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1194\/jlr.M300232-JLR200","volume":"45","author":"RK Keller","year":"2004","unstructured":"Keller, R. K., Arnold, T. P. & Fliesler, S. J. Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome. J Lipid Res 45, 347\u2013355 (2004).","journal-title":"J Lipid Res"},{"key":"19592_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/978-1-4419-1399-9_55","volume":"664","author":"SJ Fliesler","year":"2010","unstructured":"Fliesler, S. J. Retinal degeneration in a rat model of Smith-Lemli-Opitz Syndrome: thinking beyond cholesterol deficiency. Adv Exp Med Biol 664, 481\u2013489 (2010).","journal-title":"Adv Exp Med Biol"},{"key":"19592_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.nbd.2011.12.011","volume":"45","author":"L Xu","year":"2012","unstructured":"Xu, L. et al. DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model. Neurobiol Dis 45, 923\u2013929 (2012).","journal-title":"Neurobiol Dis"},{"key":"19592_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/B978-0-12-401717-7.00029-0","volume-title":"Handbook of Nutrition, Diet and the Eye","author":"SJ Fliesler","year":"2014","unstructured":"Fliesler, S. J. Retinal degeneration and cholesterol deficiency. Handbook of Nutrition, Diet and the Eye 1, (287\u2013297 (2014)."},{"key":"19592_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/(SICI)1096-9926(199609)54:3<115::AID-TERA1>3.0.CO;2-2","volume":"54","author":"M Kolf-Clauw","year":"1996","unstructured":"Kolf-Clauw, M. et al. Inhibition of 7-dehydrocholesterol reductase by the teratogen AY9944: a rat model for Smith-Lemli-Opitz syndrome. Teratology 54, 115\u2013125 (1996).","journal-title":"Teratology"},{"key":"19592_CR20","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/archopht.122.8.1190","volume":"122","author":"SJ Fliesler","year":"2004","unstructured":"Fliesler, S. J., Peachey, N. S., Richards, M. J., Nagel, B. A. & Vaughan, D. K. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features. Arch Ophthalmol 122, 1190\u20131200 (2004).","journal-title":"Arch Ophthalmol"},{"key":"19592_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1203\/pdr.0b013e318030d1cf","volume":"61","author":"SJ Fliesler","year":"2007","unstructured":"Fliesler, S. J. et al. Partial rescue of retinal function and sterol steady-state in a rat model of Smith-Lemli-Opitz syndrome. Pediatr Res 61, 273\u2013278 (2007).","journal-title":"Pediatr Res"},{"key":"19592_CR22","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1194\/jlr.M800031-JLR200","volume":"49","author":"K Boesze-Battaglia","year":"2008","unstructured":"Boesze-Battaglia, K. et al. Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndrome. J Lipid Res 49, 1488\u20131499 (2008).","journal-title":"J Lipid Res"},{"key":"19592_CR23","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1471-4159.2007.05203.x","volume":"105","author":"DA Ford","year":"2008","unstructured":"Ford, D. A. et al. Lipidomic analysis of the retina in a rat model of Smith-Lemli-Opitz syndrome: alterations in docosahexaenoic acid content of phospholipid molecular species. J Neurochem 105, 1032\u20131047 (2008).","journal-title":"J Neurochem"},{"key":"19592_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.bbalip.2012.03.001","volume":"1821","author":"L Xu","year":"2012","unstructured":"Xu, L., Sheflin, L. G., Porter, N. A. & Fliesler, S. J. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Biochim Biophys Acta 1821, 877\u2013883 (2012).","journal-title":"Biochim Biophys Acta"},{"key":"19592_CR25","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1074\/mcp.M113.027847","volume":"12","author":"C Tu","year":"2013","unstructured":"Tu, C. et al. Ion-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome. Mol Cell Proteomics 12, 3583\u20133598 (2013).","journal-title":"Mol Cell Proteomics"},{"key":"19592_CR26","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1194\/jlr.M014498","volume":"52","author":"L Xu","year":"2011","unstructured":"Xu, L. et al. An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell\/mouse models for Smith-Lemli-Opitz syndrome. J Lipid Res 52, 1222\u20131233 (2011).","journal-title":"J Lipid Res"},{"key":"19592_CR27","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1194\/jlr.M035733","volume":"54","author":"L Xu","year":"2013","unstructured":"Xu, L. et al. Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells. J Lipid Res 54, 1135\u20131143 (2013).","journal-title":"J Lipid Res"},{"key":"19592_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10545-012-9504-z","volume":"36","author":"Z Korade","year":"2013","unstructured":"Korade, Z., Xu, L., Mirnics, K. & Porter, N. A. Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome. J Inherit Metab Dis 36, 113\u2013122 (2013).","journal-title":"J Inherit Metab Dis"},{"key":"19592_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bcp.2013.03.003","volume":"86","author":"A Meljon","year":"2013","unstructured":"Meljon, A., Watson, G. L., Wang, Y., Shackleton, C. H. & Griffiths, W. J. Analysis by liquid chromatography-mass spectrometry of sterols and oxysterols in brain of the newborn Dhcr7(Delta3-5\/T93M) mouse: a model of Smith-Lemli-Opitz syndrome. Biochem Pharmacol 86, 43\u201355 (2013).","journal-title":"Biochem Pharmacol"},{"key":"19592_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1194\/jlr.M031732","volume":"54","author":"W Liu","year":"2013","unstructured":"Liu, W. et al. Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients. J Lipid Res 54, 244\u2013253 (2013).","journal-title":"J Lipid Res"},{"key":"19592_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jsbmb.2016.03.018","volume":"169","author":"WJ Griffiths","year":"2017","unstructured":"Griffiths, W. J. et al. Sterols and oxysterols in plasma from Smith-Lemli-Opitz syndrome patients. J Steroid Biochem Mol Biol 169, 77\u201387 (2017).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"19592_CR32","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1017\/S146239941100189X","volume":"13","author":"AE DeBarber","year":"2011","unstructured":"DeBarber, A. E., Eroglu, Y., Merkens, L. S., Pappu, A. S. & Steiner, R. D. Smith-Lemli-Opitz syndrome. Expert Rev Mol Med 13, e24 (2011).","journal-title":"Expert Rev Mol Med"},{"key":"19592_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1517\/21678707.2015.1014472","volume":"3","author":"SE Bianconi","year":"2015","unstructured":"Bianconi, S. E., Cross, J. L., Wassif, C. A. & Porter, F. D. Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome. Expert Opin Orphan Drugs 3, 267\u2013280 (2015).","journal-title":"Expert Opin Orphan Drugs"},{"key":"19592_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4172\/2161-1041.1000119","volume":"2","author":"SJ Fliesler","year":"2013","unstructured":"Fliesler, S. J. Antioxidants: The Missing Key to Improved Therapeutic Intervention in Smith-Lemli-Opitz Syndrome? Hereditary Genet 2, 119 (2013).","journal-title":"Hereditary Genet"},{"key":"19592_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2013.06.013","volume":"75","author":"Z Korade","year":"2014","unstructured":"Korade, Z. et al. Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome. Biol Psychiatry 75, 215\u2013222 (2014).","journal-title":"Biol Psychiatry"},{"key":"19592_CR36","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0891-5849(94)00238-F","volume":"18","author":"H Chen","year":"1995","unstructured":"Chen, H. & Tappel, A. L. Protection of vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q0, coenzyme Q10, beta-carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo. Free Radic Biol Med 18, 949\u2013953 (1995).","journal-title":"Free Radic Biol Med"},{"key":"19592_CR37","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1021\/bi00321a041","volume":"23","author":"D MacKenzie","year":"1984","unstructured":"MacKenzie, D., Arendt, A., Hargrave, P., McDowell, J. H. & Molday, R. S. Localization of binding sites for carboxyl terminal specific anti-rhodopsin monoclonal antibodies using synthetic peptides. Biochemistry 23, 6544\u20136549 (1984).","journal-title":"Biochemistry"},{"key":"19592_CR38","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1242\/jcs.154757","volume":"127","author":"ST Wavre-Shapton","year":"2014","unstructured":"Wavre-Shapton, S. T., Meschede, I. P., Seabra, M. C. & Futter, C. E. Phagosome maturation during endosome interaction revealed by partial rhodopsin processing in retinal pigment epithelium. J Cell Sci 127, 3852\u20133861 (2014).","journal-title":"J Cell Sci"},{"key":"19592_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0014-4835(91)90022-7","volume":"52","author":"KO Long","year":"1991","unstructured":"Long, K. O. & Aguirre, G. D. The cone matrix sheath in the normal and diseased retina: cytochemical and biochemical studies of peanut agglutinin-binding proteins in cone and rod-cone degeneration. Exp Eye Res 52, 699\u2013713 (1991).","journal-title":"Exp Eye Res"},{"key":"19592_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0014-4835(90)90160-V","volume":"51","author":"RN Fariss","year":"1990","unstructured":"Fariss, R. N., Anderson, D. H. & Fisher, S. K. Comparison of photoreceptor-specific matrix domains in the cat and monkey retinas. Exp Eye Res 51, 473\u2013485 (1990).","journal-title":"Exp Eye Res"},{"key":"19592_CR41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/0042-6989(68)90041-2","volume":"8","author":"KT Brown","year":"1968","unstructured":"Brown, K. T. The electroretinogram: its components and their origins. Vision Res 8, 633\u2013677 (1968).","journal-title":"Vision Res"},{"key":"19592_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2007.09.003","volume":"27","author":"AE Weymouth","year":"2008","unstructured":"Weymouth, A. E. & Vingrys, A. J. Rodent electroretinography: methods for extraction and interpretation of rod and cone responses. Prog Retin Eye Res 27, 1\u201344 (2008).","journal-title":"Prog Retin Eye Res"},{"key":"19592_CR43","first-page":"1306","volume":"12","author":"N Tserentsoodol","year":"2006","unstructured":"Tserentsoodol, N. et al. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol Vis 12, 1306\u20131318 (2006).","journal-title":"Mol Vis"},{"key":"19592_CR44","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1001\/archopht.121.12.1738","volume":"121","author":"ER Elias","year":"2003","unstructured":"Elias, E. R., Hansen, R. M., Irons, M., Quinn, N. B. & Fulton, A. B. Rod photoreceptor responses in children with Smith-Lemli-Opitz syndrome. Arch Ophthalmol 121, 1738\u20131743 (2003).","journal-title":"Arch Ophthalmol"},{"key":"19592_CR45","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.exer.2005.08.008","volume":"82","author":"DK Vaughan","year":"2006","unstructured":"Vaughan, D. K., Peachey, N. S., Richards, M. J., Buchan, B. & Fliesler, S. J. Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Exp Eye Res 82, 496\u2013504 (2006).","journal-title":"Exp Eye Res"},{"key":"19592_CR46","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.exer.2005.08.016","volume":"82","author":"MJ Richards","year":"2006","unstructured":"Richards, M. J., Nagel, B. A. & Fliesler, S. J. Lipid hydroperoxide formation in the retina: correlation with retinal degeneration and light damage in a rat model of Smith-Lemli-Opitz syndrome. Exp Eye Res 82, 538\u2013541 (2006).","journal-title":"Exp Eye Res"},{"key":"19592_CR47","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1083\/jcb.119.6.1681","volume":"119","author":"MR al-Ubaidi","year":"1992","unstructured":"al-Ubaidi, M. R. et al. Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter. J Cell Biol 119, 1681\u20131687 (1992).","journal-title":"J Cell Biol"},{"key":"19592_CR48","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1167\/iovs.03-1114","volume":"45","author":"E Tan","year":"2004","unstructured":"Tan, E. et al. Expression of cone-photoreceptor-specific antigens in a cell line derived from retinal tumors in transgenic mice. Invest Ophthalmol Vis Sci 45, 764\u2013768 (2004).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"19592_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10545-007-0537-7","volume":"30","author":"D Haas","year":"2007","unstructured":"Haas, D. et al. Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS). J Inherit Metab Dis 30, 375\u2013387 (2007).","journal-title":"J Inherit Metab Dis"},{"key":"19592_CR50","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ejhg.2008.10","volume":"16","author":"FD Porter","year":"2008","unstructured":"Porter, F. D. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 16, 535\u2013541 (2008).","journal-title":"Eur J Hum Genet"},{"key":"19592_CR51","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1203\/PDR.0b013e31819ea4eb","volume":"65","author":"YM Chan","year":"2009","unstructured":"Chan, Y. M. et al. Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome. Pediatr Res 65, 681\u2013685 (2009).","journal-title":"Pediatr Res"},{"key":"19592_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ajmg.c.31347","volume":"160C","author":"MD Svoboda","year":"2012","unstructured":"Svoboda, M. D., Christie, J. M., Eroglu, Y., Freeman, K. A. & Steiner, R. D. Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders. Am J Med Genet C Semin Med Genet 160C, 285\u2013294 (2012).","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"19592_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/gim.2016.102","volume":"19","author":"CA Wassif","year":"2017","unstructured":"Wassif, C. A. et al. A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome. Genet Med 19, 297\u2013305 (2017).","journal-title":"Genet Med"},{"key":"19592_CR54","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","volume":"24","author":"I Bjorkhem","year":"2004","unstructured":"Bjorkhem, I. & Meaney, S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24, 806\u2013815 (2004).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"19592_CR55","first-page":"4","volume":"250","author":"I Fand","year":"1981","unstructured":"Fand, I. & McNally, W. P. Whole-body localization of 14C-tocopheryl acetate in the rat following oral administration. Arch Int Pharmacodyn Ther 250, 4\u201317 (1981).","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"19592_CR56","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1194\/jlr.M041061","volume":"54","author":"K Windsor","year":"2013","unstructured":"Windsor, K. et al. Probing lipid-protein adduction with alkynyl surrogates: application to Smith-Lemli-Opitz syndrome. J Lipid Res 54, 2842\u20132850 (2013).","journal-title":"J Lipid Res"},{"key":"19592_CR57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1471-4159.2009.06326.x","volume":"111","author":"R Spector","year":"2009","unstructured":"Spector, R. Nutrient transport systems in brain: 40 years of progress. J Neurochem 111, 315\u2013320 (2009).","journal-title":"J Neurochem"},{"key":"19592_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1471-4159.2003.01854.x","volume":"86","author":"J Chen","year":"2003","unstructured":"Chen, J. & Berry, M. J. Selenium and selenoproteins in the brain and brain diseases. J Neurochem 86, 1\u201312 (2003).","journal-title":"J Neurochem"},{"key":"19592_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/10408397909527264","volume":"11","author":"FC Johnson","year":"1979","unstructured":"Johnson, F. C. The antioxidant vitamins. CRC Crit Rev Food Sci Nutr 11, 217\u2013309 (1979).","journal-title":"CRC Crit Rev Food Sci Nutr"},{"key":"19592_CR60","doi-asserted-by":"publisher","first-page":"1510S","DOI":"10.1093\/ajcn\/62.6.1510S","volume":"62","author":"AT Diplock","year":"1995","unstructured":"Diplock, A. T. Safety of antioxidant vitamins and beta-carotene. Am J Clin Nutr 62, 1510S\u20131516S (1995).","journal-title":"Am J Clin Nutr"},{"key":"19592_CR61","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1177\/41.11.7691930","volume":"41","author":"SR Shi","year":"1993","unstructured":"Shi, S. R., Chaiwun, B., Young, L., Cote, R. J. & Taylor, C. R. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem 41, 1599\u20131604 (1993).","journal-title":"J Histochem Cytochem"},{"key":"19592_CR62","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/S0022-2275(20)42108-X","volume":"31","author":"H Oda","year":"1990","unstructured":"Oda, H., Yamashita, H., Kosahara, K., Kuroki, S. & Nakayama, F. Esterified and total 7 alpha-hydroxycholesterol in human serum as an indicator for hepatic bile acid synthesis. J Lipid Res 31, 2209\u20132218 (1990).","journal-title":"J Lipid Res"}],"updated-by":[{"DOI":"10.1038\/s41598-018-22647-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19592-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19592-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19592-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:20:37Z","timestamp":1671585637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19592-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,19]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19592"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19592-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,19]]},"assertion":[{"value":"21 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1286"}}